June 4th, 2014
GlaxoSmithKline to pay $105 million over improper drug marketing
By N.C. Department of Justice
Raleigh: Drug manufacturer GlaxoSmithKline will pay North Carolina and 44 other states $105 million to settle allegations that the company unlawfully marketed drugs, Attorney General Roy Cooper said Wednesday.
“Drug companies have an obligation to market drugs only for purposes that are safe and effective,” Cooper said. “The drug approval process is designed to protect the health of consumers, and it’s important that process be followed.” Cooper’s Consumer Protection Division filed a complaint and consent judgment in Wake County Superior Court against GlaxoSmithKline, LLC (GSK) this morning. North Carolina will receive $2.5 million as its share of the judgment.